Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $1.9 million.

  • Conmed's Net Cash Flow rose 11574.92% to $1.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $13.9 million, marking a year-over-year increase of 38242.02%. This contributed to the annual value of $13.9 million for FY2025, which is 38242.02% up from last year.
  • As of Q4 2025, Conmed's Net Cash Flow stood at $1.9 million, which was up 11574.92% from $5.0 million recorded in Q3 2025.
  • Conmed's 5-year Net Cash Flow high stood at $29.6 million for Q2 2022, and its period low was -$18.5 million during Q3 2022.
  • Its 5-year average for Net Cash Flow is $793650.0, with a median of $1.6 million in 2023.
  • Examining YoY changes over the last 5 years, Conmed's Net Cash Flow showed a top increase of 487557.6% in 2021 and a maximum decrease of 223806.34% in 2021.
  • Over the past 5 years, Conmed's Net Cash Flow (Quarter) stood at -$10.2 million in 2021, then soared by 37.2% to -$6.4 million in 2022, then fell by 12.89% to -$7.2 million in 2023, then tumbled by 62.91% to -$11.8 million in 2024, then soared by 115.75% to $1.9 million in 2025.
  • Its Net Cash Flow stands at $1.9 million for Q4 2025, versus $5.0 million for Q3 2025 and -$3.1 million for Q2 2025.